to Content

Dr. Josef Martin PENNINGER Wissenschaftlicher Direktor, Institut für Molekulare Biotechnologie GmbH, Österreichische Akademie der Wissenschaften, Wien

CV

  Princess Margaret Hospital, Toronto
1994-2003 Associate Scientist, The Ontario Cancer Institute, Dept. Of Molecular and Cellular Biology,
since 1998 Associate Professor (Dozent), Department of Experimental and General Pathology, University of Innsbruck, Austria
2002-2004 Full Professor, Departments of Immunology and Medical Biophysics, University of Toronto, Canada
  Sciences, Vienna, Austria
since 2002 Scientific and Administrative Director, IMBA, Institute for Molecular Biotechnology of the Austrian Academy of
since 2004 Adjunct Full Professor, Departments of Immunology and Medical Biophysics, University of Toronto, Canada
since 2004 Honorary Professor of Genetics, University of Vienna, Austria
since 2004 Honorary Professor, Chinese Academy of Medical Sciences, Beijing

Publications

most recent:
Identification of the molecular scaffold Gab2 as a crucial component of RANK signaling and osteoclastogenesis, Nature Medicine, 2005
Identification of the SARS-coronavirus receptor ACE2 as a crucial factor in SARS pathogenesis, Nature Medicine, 2005
First paper to show that ACE2 protects from Severe Acute Lung Failure, Nature, 2005
Identification of a novel soil factor, RANKL/RANK, that could explain selective cancer metastases to bones, Nature, 2006
First identification of genes that control electricity regulated wound healing, Nature, 2006
Identification of collectrin as novel regulator of amino acid transport, Nature, 2006

Awards

Landeskulturpreis für Wissenschaft von Oberösterreich (Culture Prize for Science from the province of Upper Austria), 2003
International Research Prize in Bone Research, 2003
Austrian Scientist of the Year Award, 2003
Austrian 04 award, 2004
Young Global Leader (The Forum of Young Global Leaders/World Economic Forum), 2005
Ernst-Jung-Preis für Medizin, 2007
Descartes Price (highest science price in EU), 2007